Small molecule oxidation products trigger disease-associated protein misfolding

被引:89
作者
Bieschke, Jan [1 ]
Zhang, Qinghai [1 ]
Bosco, Daryl A. [1 ]
Lerner, Richard A. [1 ]
Powers, Evan T. [1 ]
Wentworth, Paul, Jr. [1 ]
Kelly, Jeffery W. [1 ]
机构
[1] Scripps Res Inst, La Jolla, CA 92037 USA
关键词
D O I
10.1021/ar0500766
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Oxidative stress and inflammation are risk factors for both the development of alpha-synucleinopathies, such as Parkinson's disease and dementia with Lewy bodies, and Alzheimer's disease, the two most common neurodegenerative disorders. These diseases are associated with the neurotoxic deposition of misassembled alpha-synuclein and amyloid-beta (A beta) peptides, respectively. Both occur sporadically, that is, without detectable disease-related mutations, in the vast majority of cases. Small molecule oxidation products, especially secosterols derived from cholesterol and 4-hydroxynonenal derived from lipid peroxidation, found in afflicted brains, accelerate the misassembly of both A beta and alpha-synuclein. This Account explores the mechanism of small molecule oxidation product-mediated protein misassembly and possible intervention strategies.
引用
收藏
页码:611 / 619
页数:9
相关论文
共 70 条
[1]   Histochemical detection of 4-hydroxynonenal protein in Alzheimer amyloid [J].
Ando, Y ;
Brännström, T ;
Uchida, K ;
Nyhlin, N ;
Näsman, B ;
Suhr, O ;
Yamashita, T ;
Olsson, T ;
El Salhy, M ;
Uchino, M ;
Ando, M .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 1998, 156 (02) :172-176
[2]  
[Anonymous], 1982, FREE RADIC LIPID PER
[3]   Lipid peroxidation in neurodegeneration: new insights into Alzheimer's disease [J].
Arlt, S ;
Beisiegel, U ;
Kontush, A .
CURRENT OPINION IN LIPIDOLOGY, 2002, 13 (03) :289-294
[4]   Investigating antibody-catalyzed ozone generation by human neutrophils [J].
Babior, BM ;
Takeuchi, C ;
Ruedi, J ;
Gutierrez, A ;
Wentworth, P .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (06) :3031-3034
[5]   Oxidative metabolites accelerate Alzheimer's amyloidogenesis by a two-step mechanism, eliminating the requirement for nucleation [J].
Bieschke, J ;
Zhang, QH ;
Powers, ET ;
Lerner, RA ;
Kelly, JW .
BIOCHEMISTRY, 2005, 44 (13) :4977-4983
[6]   Elucidation of primary structure elements controlling early amyloid β-protein oligomerization [J].
Bitan, G ;
Vollers, SS ;
Teplow, DB .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (37) :34882-34889
[7]   Elevated levels of oxidized cholesterol metabolites in Lewy body disease brains accelerate α-synuclein fibrilization [J].
Bosco, DA ;
Fowler, DM ;
Zhang, QH ;
Nieva, J ;
Powers, ET ;
Wentworth, P ;
Lerner, RA ;
Kelly, JW .
NATURE CHEMICAL BIOLOGY, 2006, 2 (05) :249-253
[8]   Molecular pathways to neurodegeneration [J].
Bossy-Wetzel, E ;
Schwarzenbacher, R ;
Lipton, SA .
NATURE MEDICINE, 2004, 10 (07) :S2-S9
[9]   Aldehyde-sequestering drugs: tools for studying protein damage by lipid peroxidation products [J].
Burcham, PC ;
Kaminskas, LM ;
Fontaine, FR ;
Petersen, DR ;
Pyke, SM .
TOXICOLOGY, 2002, 181 :229-236
[10]   Huntington's disease age-of-onset linked to polyglutamine aggregation nucleation [J].
Chen, SM ;
Ferrone, FA ;
Wetzel, R .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (18) :11884-11889